Solesence earnings release, August 20, 2026

Solesence, Inc. (SLSN) · Form 8-K, Item 2.02 · Filed · SEC filing

Solésence Reports Second Quarter 2026 Financial Results

Quarterly Report Filed on Form 10-Q

Company to Host Conference Call at 5:00 p.m. ET Today

ROMEOVILLE, Ill., Aug. 19, 2026 (GLOBE NEWSWIRE) -- Solésence, Inc. (Nasdaq: SLSN), a leader in scientifically driven health care solutions across beauty and life science categories, today reported its financial results for the second quarter ended June 30, 2026.

“In the second quarter, our business focused on operational execution and financial discipline as we continue implementing our Transform and Transcend strategy,” said Kevin Cureton, President and Chief Executive Officer. “By leveraging our intellectual property to enter high-growth markets, and expanding our co-marketing initiatives, we are solidifying our position as a trusted partner to premier brands. Combined with our targeted operational efficiency initiatives, these efforts ensure Solésence remains lean, agile, and structured for long-term value creation.”

Second Quarter 2026 Financial Highlights

Second-quarter revenue was $15.3 million, compared to $20.4 million in the second quarter of 2025. Results in the prior-year period benefited from a one-time revenue boost driven by a major Solésence product launch and initial inventory pipeline fill.

Gross profit in the second quarter was $4.7 million, compared to $6.4 million for the same period in 2025.

Gross margin in the second quarter was 31%, compared to 32% for the same period in 2025.

Net loss in the second quarter was $158,000, compared to net income of $3.2 million for the same period in 2025.

Accounting Update

As previously disclosed, the Company filed a Form NT 10-Q regarding its quarterly report for the period ended June 30, 2026. The Company has completed its evaluation regarding historical inventory costing allocation methodologies. The Company’s Quarterly Report on Form 10-Q for the second quarter ended June 30, 2026, has been filed with the U.S. Securities and Exchange Commission (SEC) and is accessible on the SEC’s website at www.sec.gov as well as in the Investor Relations section of the Company’s website at ir.solesence.com.

Second Quarter 2026 Conference Call Details

Date/Time:

Wednesday, August 19, 2026 – 4:00 p.m. CT, 5:00 p.m. ET

Speakers

: Kevin Cureton, President & Chief Executive Officer and Laura Riffner, Chief Financial Officer

Webcast Link

: https://edge.media-server.com/mmc/p/ecgoveo8/

Dial-In Link

: https://register-conf.media-server.com/register/BIb4a184933a544641a8f41396efd90a13

To receive the dial-in number, as well as your personalized PIN, you must register at the above link. Once registered, you will also have the option to have the system dial-out to you once the conference call begins. If you forget your PIN prior to the conference call, you can simply re-register.

The call may also be accessed through the Company’s investor relations website, at https://ir.solesence.com/. Please join the conference call at least five minutes before the start time.

About Solésence, Inc.

Solésence, Inc. (Nasdaq: SLSN) is a leader in scientifically-driven health care solutions across beauty and life science categories. With a mission to deliver joy through innovation, inclusivity and the science of beautiful skin, we have redefined mineral-based sun protection by maximizing transparency, effectiveness, aesthetics, and wearability — empowering individuals to embrace beauty on their own terms. Combining best-in-class skin health solutions with the celebration of self-care, we allow brands to deliver unique product claims and attributes by seamlessly integrating protection, prevention, and treatment technologies into daily use products. Learn more at solesence.com.

Financial statements

Income Statement

SOLESENCE, INC — investors@solesence.com (in thousands except share and per share data)

SOLESENCE, INC – CONSOLIDATED STATEMENTS OF OPERATIONS – (Unaudited Consolidated Condensed) – Three months ended – June 30, – 2026SOLESENCE, INC – CONSOLIDATED STATEMENTS OF OPERATIONS – (Unaudited Consolidated Condensed) – Three months ended – June 30, – 2025SOLESENCE, INC – CONSOLIDATED STATEMENTS OF OPERATIONS – (Unaudited Consolidated Condensed) – Six months ended – June 30, – 2026SOLESENCE, INC – CONSOLIDATED STATEMENTS OF OPERATIONS – (Unaudited Consolidated Condensed) – Six months ended – June 30, – 2025
Revenue:Product revenue15,28620,26128,20534,836
Revenue:Other revenue469885148
Revenue:Net revenue15,33220,35928,29034,984
Revenue:Cost of revenue10,58413,91620,40024,895
Revenue:Gross profit4,7486,4437,89010,089
Operating expense:Research and development expense9479551,9901,973
Operating expense:Selling, general and administrative expense3,6803,0126,4795,120
Operating expense:Net (loss) income from operations1212,476-5792,996
Interest incomeInterest expense27987543263
Interest incomeOther nonoperating income1,23421,234
Interest incomeNet (loss) income before provision for income taxes-1583,623-1,1203,967
Interest incomeProvision for income taxes390390
Interest incomeNet (loss) income-1583,233-1,1203,577
Interest incomeNet (loss) income per share-basic$-0.04-0.020.05
Interest incomeWeighted average number of common shares outstanding - basic70,637,19970,200,03970,631,38070,151,928
Interest incomeNet (loss) income per share-diluted$-0.04-0.020.05
Interest incomeWeighted average number of common shares outstanding - diluted70,637,19972,580,67970,631,38072,497,929

Balance Sheet

SOLESENCE, INC — investors@solesence.com (in thousands)

SOLESENCE, INC – CONSOLIDATED BALANCE SHEETS – (Unaudited Consolidated Condensed) – June 30, – 2026 – (Unaudited)SOLESENCE, INC – CONSOLIDATED BALANCE SHEETS – (Unaudited Consolidated Condensed) – December 31, – 2025 – (Unaudited)
Current assets:Cash1,0461,288
Current assets:Trade accounts receivable10,2407,642
Current assets:Allowance for credit losses-895-806
Current assets:Trade accounts receivable, net9,3456,836
Current assets:Inventories, net12,95714,963
Current assets:Prepaid expenses and other current assets1,9222,141
Current assets:Total current assets25,27025,228
Current assets:Equipment and leasehold improvements, net14,79414,329
Current assets:Operating leases, right of use6,3376,913
Current assets:Other assets, net3637
Current assets:Total assets46,43746,507
Current liabilities:Line of credit, accounts receivable, related party3,7874,767
Current liabilities:Current portion of line of credit, inventory, related party9,500
Current liabilities:Current portion of debt, related parties1,000
Current liabilities:Current portion of operating lease obligations1,3431,255
Current liabilities:Accounts payable4,9684,098
Current liabilities:Deferred revenue1,937930
Current liabilities:Accrued expenses3,4782,879
Current liabilities:Total current liabilities26,01313,929
Current liabilities:Long-term portion of operating lease obligations7,0707,798
Current liabilities:Long-term portion of line of credit, inventory, related party9,500
Current liabilities:Long-term portion of debt, related parties1,000
Current liabilities:Asset retirement obligations200194
Current liabilities:Total long-term liabilities7,27018,492
70,632,445 and 70,614,045 shares issued and outstanding on March 31, 2026and December 31, 2025, respectively706706
70,632,445 and 70,614,045 shares issued and outstanding on March 31, 2026Additional paid-in capital115,754115,566
70,632,445 and 70,614,045 shares issued and outstanding on March 31, 2026Accumulated deficit-103,306-102,186
70,632,445 and 70,614,045 shares issued and outstanding on March 31, 2026Total stockholders' equity13,15414,086
70,632,445 and 70,614,045 shares issued and outstanding on March 31, 2026Total liabilities and shareholders' equity46,43746,507
Full release

Forward-Looking Statements

This press release contains words such as “expects,” “shall,” “will,” “believes,” and similar expressions that are intended to identify forward-looking statements within the meaning of the Safe Harbor Provisions of the Private Securities Litigation Reform Act of 1995. Such statements in this announcement are made based on the Company’s current beliefs, known events and circumstances at the time of publication, and as such, are subject in the future to unforeseen risks and uncertainties that could cause the Company’s results of operations, performance, and achievements to differ materially from current expectations expressed in, or implied by, these forward-looking statements. These risks and uncertainties include, without limitation, the following: a decision by a customer to cancel a purchase order or supply agreement in light of the Company’s dependence on a limited number of key customers; uncertain demand for, and acceptance of, the Company’s engineered materials, ingredients, and fully formulated products; the Company’s manufacturing capacity and product mix flexibility in light of customer demand; the Company’s limited marketing experience; changes in development and distribution relationships; the impact of competitive products and technologies; the Company’s dependence on patents and protection of proprietary information; the resolution of litigation in which the Company may become involved; the impact of any potential new government regulations that could be difficult to respond to or too costly to comply with while remaining financially viable; the ability of the Company to maintain an appropriate electronic trading venue; and other factors described in the Company’s Form 10-K filed March 31, 2026. In addition, the Company’s forward-looking statements could be affected by general industry and market conditions and growth rates. Except as required by federal securities laws, the Company undertakes no obligation to update or revise these forward-looking statements to reflect new events, uncertainties, or other contingencies.

Media Contact: media@solesence.com

Investor Relations Contact: investors@solesence.com

Earlier releases

From SEC EDGAR. Analysis by Pear Digitals from the filing alone. Not investment advice. · Latest earnings · Markdown

Screener

Plans

Premium and Pro coming soon.

Log in

New here?

Join the waitlist

Pear FMV opens to everyone soon. We'll email you when it does.